Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accel
Go back to Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accel| Quantum Technology Corp (NASDAQ: QNTM) | Delayed: 3.80 -0.13 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.93 | 52 Week High | $2.00 | |||
| Open | $3.93 | 52 Week Low | $0.10 | |||
| Day High | $4.01 | P/E | N/A | |||
| Day Low | $3.64 | EPS | $0.00 | |||
| Volume | 104,356 | |||||
| Quantum Technology Corp (NASDAQ: QNTM) | Delayed: 3.80 -0.13 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.93 | 52 Week High | $2.00 | |||
| Open | $3.93 | 52 Week Low | $0.10 | |||
| Day High | $4.01 | P/E | N/A | |||
| Day Low | $3.64 | EPS | $0.00 | |||
| Volume | 104,356 | |||||
